These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8679358)

  • 1. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Petersen KL; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1996 Jun; 76(6):829-34. PubMed ID: 8679358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of systemic N-methyl-D-aspartate receptor antagonist (dextromethorphan) on primary and secondary hyperalgesia in humans.
    Ilkjaer S; Dirks J; Brennum J; Wernberg M; Dahl JB
    Br J Anaesth; 1997 Nov; 79(5):600-5. PubMed ID: 9422898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery.
    Stubhaug A; Breivik H; Eide PK; Kreunen M; Foss A
    Acta Anaesthesiol Scand; 1997 Oct; 41(9):1124-32. PubMed ID: 9366932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oral ketamine on secondary hyperalgesia, thermal and mechanical pain thresholds, and sedation in humans.
    Mikkelsen S; Jørgensen H; Larsen PS; Brennum J; Dahl JB
    Reg Anesth Pain Med; 2000; 25(5):452-8. PubMed ID: 11009229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.
    Warncke T; Stubhaug A; Jørum E
    Pain; 1997 Aug; 72(1-2):99-106. PubMed ID: 9272793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of naloxone on ketamine-induced effects on hyperalgesia and ketamine-induced side effects in humans.
    Mikkelsen S; Ilkjaer S; Brennum J; Borgbjerg FM; Dahl JB
    Anesthesiology; 1999 Jun; 90(6):1539-45. PubMed ID: 10360849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preinjury treatment with morphine or ketamine inhibits the development of experimentally induced secondary hyperalgesia in man.
    Warncke T; Stubhaug A; Jørum E
    Pain; 2000 Jun; 86(3):293-303. PubMed ID: 10812259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of Ketamine on stimulation of primary and secondary hyperalgesic areas induced by capsaicin--a double-blind, placebo-controlled, human experimental study.
    Andersen OK; Felsby S; Nicolaisen L; Bjerring P; Jensen TS; Arendt-Nielsen L
    Pain; 1996 Jul; 66(1):51-62. PubMed ID: 8857631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
    Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
    Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
    Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
    Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
    Jørum E; Warncke T; Stubhaug A
    Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor.
    Willert RP; Woolf CJ; Hobson AR; Delaney C; Thompson DG; Aziz Q
    Gastroenterology; 2004 Mar; 126(3):683-92. PubMed ID: 14988822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppressive effects of ketamine on neuropathic pain].
    Sonoda H; Omote K
    Masui; 1998 Feb; 47(2):136-44. PubMed ID: 9513324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Nefopam Infusion during Laparascopic Cholecystectomy on Postoperative Pain.
    Kim EM; Jeon JH; Chung MH; Choi EM; Baek SH; Jeon PH; Lee MH
    Int J Med Sci; 2017; 14(6):570-577. PubMed ID: 28638273
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of ketamine on the temporal summation (wind-up) of the R(III) nociceptive flexion reflex and pain in humans.
    Guirimand F; Dupont X; Brasseur L; Chauvin M; Bouhassira D
    Anesth Analg; 2000 Feb; 90(2):408-14. PubMed ID: 10648330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S(+)-ketamine effect on experimental pain and cardiac output: a population pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
    Sigtermans M; Dahan A; Mooren R; Bauer M; Kest B; Sarton E; Olofsen E
    Anesthesiology; 2009 Oct; 111(4):892-903. PubMed ID: 19741495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Low doses ketamine: antihyperalgesic drug, non-analgesic].
    Richebé P; Rivat C; Rivalan B; Maurette P; Simonnet G
    Ann Fr Anesth Reanim; 2005; 24(11-12):1349-59. PubMed ID: 16115745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local treatment with the N-methyl-D-aspartate receptor antagonist ketamine, inhibit development of secondary hyperalgesia in man by a peripheral action.
    Warncke T; Jørum E; Stubhaug A
    Neurosci Lett; 1997 May; 227(1):1-4. PubMed ID: 9178844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topically administered ketamine reduces capsaicin-evoked mechanical hyperalgesia.
    Pöyhiä R; Vainio A
    Clin J Pain; 2006 Jan; 22(1):32-6. PubMed ID: 16340591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ketamine as an NMDA receptor antagonist].
    Kushikata T; Hirota K
    Masui; 2013 Jan; 62(1):38-43. PubMed ID: 23431892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.